200 related articles for article (PubMed ID: 24074812)
1. The General Surgeon's quandary: atypical lipomatous tumor vs lipoma, who needs a surgical oncologist?
Fisher SB; Baxter KJ; Staley CA; Fisher KE; Monson DK; Murray DR; Oskouei SV; Weiss SW; Kooby DA; Maithel SK; Delman KA
J Am Coll Surg; 2013 Nov; 217(5):881-8. PubMed ID: 24074812
[TBL] [Abstract][Full Text] [Related]
2. Developing a clinical scoring system to differentiate deep-seated atypical lipomatous tumor from lipoma of soft tissue.
Cheng Y; Ko AT; Huang JH; Lee BC; Yang RS; Liang CW; Tai HC; Cheng NC
Asian J Surg; 2019 Aug; 42(8):832-838. PubMed ID: 30711441
[TBL] [Abstract][Full Text] [Related]
3. Non-Radiographic Risk Factors Differentiating Atypical Lipomatous Tumors from Lipomas.
Bird JE; Morse LJ; Feng L; Wang WL; Lin PP; Moon BS; Lazar AJ; Satcher RL; Madewell JE; Lewis VO
Front Oncol; 2016; 6():197. PubMed ID: 27713864
[TBL] [Abstract][Full Text] [Related]
4. Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status.
Knebel C; Neumann J; Schwaiger BJ; Karampinos DC; Pfeiffer D; Specht K; Lenze U; von Eisenhart-Rothe R; Rummeny EJ; Woertler K; Gersing AS
BMC Cancer; 2019 Apr; 19(1):309. PubMed ID: 30943944
[TBL] [Abstract][Full Text] [Related]
5. Image-Guided Core Needle Biopsy of Adipocytic Tumors: Diagnostic Accuracy and Concordance With Final Surgical Pathology.
Thavikulwat AC; Wu JS; Chen X; Anderson ME; Ward A; Kung J
AJR Am J Roentgenol; 2021 Apr; 216(4):997-1002. PubMed ID: 33624523
[No Abstract] [Full Text] [Related]
6. MDM2 Amplification in Problematic Lipomatous Tumors: Analysis of FISH Testing Criteria.
Clay MR; Martinez AP; Weiss SW; Edgar MA
Am J Surg Pathol; 2015 Oct; 39(10):1433-9. PubMed ID: 26146760
[TBL] [Abstract][Full Text] [Related]
7. Lipomatous Soft Tissue Masses: Challenging the Paradigm of Routine Preoperative Biopsy.
McClintock NC; Satyananda V; Dauphine C; Hari DM; Chen KT; Ozao-Choy JJ
J Surg Res; 2020 Mar; 247():103-107. PubMed ID: 31767281
[TBL] [Abstract][Full Text] [Related]
8. Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors.
Zhang H; Erickson-Johnson M; Wang X; Oliveira JL; Nascimento AG; Sim FH; Wenger DE; Zamolyi RQ; Pannain VL; Oliveira AM
Am J Surg Pathol; 2010 Sep; 34(9):1304-11. PubMed ID: 20679883
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of lipoma and atypical lipomatous tumor by a scoring system: implication of increased vascularity on pathogenesis of liposarcoma.
Nagano S; Yokouchi M; Setoguchi T; Ishidou Y; Sasaki H; Shimada H; Komiya S
BMC Musculoskelet Disord; 2015 Feb; 16():36. PubMed ID: 25879189
[TBL] [Abstract][Full Text] [Related]
10. Deep-seated, well differentiated lipomatous tumors of the chest wall and extremities: the role of cytogenetics in classification and prognostication.
Bassett MD; Schuetze SM; Disteche C; Norwood TH; Swisshelm K; Chen X; Bruckner J; Conrad EU; Rubin BP
Cancer; 2005 Jan; 103(2):409-16. PubMed ID: 15593324
[TBL] [Abstract][Full Text] [Related]
11. MDM2 RNA In Situ Hybridization for the Diagnosis of Atypical Lipomatous Tumor: A Study Evaluating DNA, RNA, and Protein Expression.
Kulkarni AS; Wojcik JB; Chougule A; Arora K; Chittampalli Y; Kurzawa P; Mullen JT; Chebib I; Nielsen GP; Rivera MN; Ting DT; Deshpande V
Am J Surg Pathol; 2019 Apr; 43(4):446-454. PubMed ID: 30520819
[TBL] [Abstract][Full Text] [Related]
12. A scoring system combining clinical, radiological, and histopathological examinations for differential diagnosis between lipoma and atypical lipomatous tumor/well-differentiated liposarcoma.
Asano Y; Miwa S; Yamamoto N; Hayashi K; Takeuchi A; Igarashi K; Yonezawa H; Araki Y; Morinaga S; Nojima T; Ikeda H; Tsuchiya H
Sci Rep; 2022 Jan; 12(1):237. PubMed ID: 34997060
[TBL] [Abstract][Full Text] [Related]
13. MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 gene amplification.
Brisson M; Kashima T; Delaney D; Tirabosco R; Clarke A; Cro S; Flanagan AM; O'Donnell P
Skeletal Radiol; 2013 May; 42(5):635-47. PubMed ID: 22987247
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of MRI and histology in assessment of deep lipomatous tumours.
Cairncross L; Snow HA; Strauss DC; Smith MJF; Sjokvist O; Messiou C; Thway K; Hayes AJ
Br J Surg; 2019 Dec; 106(13):1794-1799. PubMed ID: 31502664
[TBL] [Abstract][Full Text] [Related]
15. [Subfascial lipomatous tumors: management in a series of 37 consecutive cases].
Gouin F; Bertrand-Vasseur A; Collet T; Moreau A; Leaute F; Rolland F; Cussac A; Passuti N
Rev Chir Orthop Reparatrice Appar Mot; 2001 Oct; 87(6):585-95. PubMed ID: 11685150
[TBL] [Abstract][Full Text] [Related]
16. Quantitative signal intensity ratios to distinguish between subfascial lipoma and atypical lipomatous tumor/well-differentiated liposarcoma using short-tau inversion recovery (STIR) MRI.
Donners R; Krieg AH; Baumhoer D; Boll DT; Harder D
Diagn Interv Imaging; 2020 Jun; 101(6):383-390. PubMed ID: 32107197
[TBL] [Abstract][Full Text] [Related]
17. Differences in MRI findings of superficial spindle cell lipoma and atypical lipomatous tumor/well-differentiated liposarcoma.
Kawaguchi M; Kato H; Kobayashi K; Miyazaki T; Nagano A; Noda Y; Hyodo F; Matsuo M
Br J Radiol; 2023 Mar; 96(1143):20220743. PubMed ID: 36607278
[TBL] [Abstract][Full Text] [Related]
18. Low Recurrence Rate and Risk of Distant Metastases following Marginal Surgery of Intramuscular Lipoma and Atypical Lipomatous Tumors of the Extremities and Trunk Wall.
Presman B; Jauffred SF; Kornø MR; Petersen MM
Med Princ Pract; 2020; 29(3):203-210. PubMed ID: 31550705
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of truncal and extremities atypical lipomatous tumors/well-differentiated liposarcoma: A systematic review of the literature.
Choi KY; Jost E; Mack L; Bouchard-Fortier A
Am J Surg; 2020 May; 219(5):823-827. PubMed ID: 32029218
[TBL] [Abstract][Full Text] [Related]
20. Differential Diagnosis of Lipomatous Tumors Using
Oshiro H; Mizuta K; Tsuha Y; Aoki Y; Katsuki R; Tome Y; Nishida K
Cancer Diagn Progn; 2024; 4(2):141-146. PubMed ID: 38434912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
